Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 8, 2021
[The Impact of Induction Treatment Response on the Prognosis of Pediatric Core Binding Factor-Acute Myeloid Leukemia Patients]Hui-Min Zeng, Guan-Hua Hu, Ai-Dong Lu, et al.
Cancer Research and Treatment|February 14, 2024
CD19-Specific CAR-T Cell Treatment of 115 Children and Young Adults with Acute B Lymphoblastic Leukemia: Long-term Follow-upYu Wang, Yu-Juan Xue, Ying-Xi Zuo, et al.
Frontiers in Oncology|January 31, 2024
Prognostic significance of Wilms' tumor gene 1 expression in children with B-cell precursor acute lymphoblastic leukemiaYu-Juan Xue, Yu Wang, Le-Ping Zhang, et al.
Biochemical Pharmacology|June 14, 2022
Itaconate alleviates β<sub>2</sub>-microglobulin-induced cognitive impairment by enhancing the hippocampal amino-β-carboxymuconate-semialdehyde-decarboxylase/picolinic acid pathwayGui-Juan Zhou, Yi-Yun Tang, Jin-Xi Zuo, et al.
Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics|June 25, 2013
[Therapeutic effect of clofarabine in children with relapsed or refractory acute lymphoblastic leukemia]Pan Suo, Le-Ping Zhang, Jun Wu, et al.
Pediatric Hematology and Oncology|October 3, 2024
Long-Term Survival and Immune Reconstitution of Donor-Derived Chimeric Antigen Receptor T-Cell Therapy for Childhood Molecular Relapse of B-Cell Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Stem Cell TransplantationGuan-Hua Hu, Ying-Xi Zuo, Pan Suo, et al.
Plos One|December 5, 2025
Trends in cognitive outcomes in middle-aged Americans across three birth cohortsRebecca T Brown, Xi Zuo, Corey T McMillan, et al.
BMC Public Health|May 1, 2026
Association between self-purchased medication use and gastric disease among Chinese adults: a cross-sectional analysis based on CHARLS 2018 dataHui-Yun Hou, Yan Wang, Peng-Xi Zuo, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 20, 2023
Clinical Analysis of Pediatric T-Cell Acute Lymphoblastic Leukemia Using the MRD-Oriented Strategy SystemYu-Juan Xue, Yu Wang, Ai-Dong Lu, et al.
Leukemia & Lymphoma|January 7, 2026
Efficacy and safety of inotuzumab ozogamicin as the definitive therapeutic option prior to allogeneic hematopoietic stem cell transplantation for pediatric relapsed/refractory B-cell acute lymphoblastic leukemiaGuan-Hua Hu, Ying-Xi Zuo, Xiao-Hui Zhang, et al.
Pageof 6